Kadimastem - Stem Cell to Cure Diseases

Drug Discovery > Overview

Collaboration for Optimizing Drug Development through pluripotent stem cell-derived cells

Kadimastem’s unique capabilities, based on years of pioneering research and development at the Weizmann Institute of Science  and beyond, has enabled the establishment of high throughput screening systems for identifying lead drug candidates. Our system is capable of screening compounds automatically and quantifies the readouts using a cell-based High Content Screening (HCS) system.  

System Highlights:

  • Unique accesses to human cell sources
  • Reproducible methods
  • Relatively high throughput
  • High accuracy
  • Comprehensive and cost efficient
  • Shortens hit to lead phase